Published in Nat Med on February 23, 2015
Designer matrices for intestinal stem cell and organoid culture. Nature (2016) 1.51
Sequential cancer mutations in cultured human intestinal stem cells. Nature (2015) 1.48
An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis Suppression. Cancer Cell (2016) 1.48
A recellularized human colon model identifies cancer driver genes. Nat Biotechnol (2016) 1.47
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer (2017) 1.39
Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev Cancer (2015) 1.32
Organoids as an in vitro model of human development and disease. Nat Cell Biol (2016) 1.27
Engineering Stem Cell Organoids. Cell Stem Cell (2016) 1.15
Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer. Nat Biotechnol (2017) 1.10
Induced Pluripotent Stem Cells Meet Genome Editing. Cell Stem Cell (2016) 1.06
In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol (2017) 1.04
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice. Nat Commun (2016) 1.00
Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome. Epigenetics Chromatin (2015) 0.99
Wnt signaling in cancer. Oncogene (2016) 0.95
Organoid Models of Human Gastrointestinal Development and Disease. Gastroenterology (2016) 0.92
CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo. Sci Rep (2016) 0.90
Cornerstones of CRISPR-Cas in drug discovery and therapy. Nat Rev Drug Discov (2016) 0.88
A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. Cancer Res (2016) 0.87
Colorectal cancer: role of commensal bacteria and bystander effects. Gut Microbes (2015) 0.87
Modeling Disease In Vivo With CRISPR/Cas9. Trends Mol Med (2015) 0.87
PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype. Nat Commun (2015) 0.86
Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2. PLoS Genet (2015) 0.86
Preclinical models of pancreatic ductal adenocarcinoma. J Pathol (2015) 0.83
Tissue Engineering and Regenerative Medicine 2015: A Year in Review. Tissue Eng Part B Rev (2016) 0.82
Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance. Oncotarget (2015) 0.82
Mouse models of intestinal cancer. J Pathol (2015) 0.81
Three-Dimensional Gastrointestinal Organoid Culture in Combination with Nerves or Fibroblasts: A Method to Characterize the Gastrointestinal Stem Cell Niche. Stem Cells Int (2015) 0.81
The present and future of genome editing in cancer research. Hum Genet (2016) 0.81
Fbxw7-associated drug resistance is reversed by induction of terminal differentiation in murine intestinal organoid culture. Mol Ther Methods Clin Dev (2016) 0.81
Toward recreating colon cancer in human organoids. Nat Med (2015) 0.81
Determinants of metastatic competency in colorectal cancer. Mol Oncol (2017) 0.80
Human mini-guts: new insights into intestinal physiology and host-pathogen interactions. Nat Rev Gastroenterol Hepatol (2016) 0.80
Modeling pancreatic cancer with organoids. Trends Cancer (2016) 0.79
Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology. Annu Rev Nutr (2016) 0.79
The CEA-/lo colorectal cancer cell population harbors cancer stem cells and metastatic cells. Oncotarget (2016) 0.79
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma. Cancer Lett (2016) 0.78
Integrated analysis of long non-coding RNAs in human colorectal cancer. Oncotarget (2016) 0.78
Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection. PLoS Genet (2016) 0.78
Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc Natl Acad Sci U S A (2017) 0.77
Organoid modeling for cancer precision medicine. Genome Med (2015) 0.77
Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures. J Biomol Screen (2016) 0.77
The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery. Cell Oncol (Dordr) (2016) 0.77
Visualization and targeting of LGR5(+) human colon cancer stem cells. Nature (2017) 0.75
E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling. Proc Natl Acad Sci U S A (2017) 0.75
Organoid technologies meet genome engineering. EMBO Rep (2017) 0.75
CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling. Int J Mol Sci (2015) 0.75
Genome engineering of stem cell organoids for disease modeling. Protein Cell (2017) 0.75
The cluster microRNAs miR-194 and miR-215 suppress the tumorigenicity of intestinal tumor organoids. Cancer Sci (2017) 0.75
The role of enterocyte defects in the pathogenesis of congenital diarrheal disorders. Dis Model Mech (2016) 0.75
A stable but reversible integrated surrogate reporter for assaying CRISPR/Cas9-stimulated homology-directed repair. J Biol Chem (2017) 0.75
Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells. Oncogene (2016) 0.75
Wnt Signaling and Colorectal Cancer. Curr Colorectal Cancer Rep (2017) 0.75
Drug Discovery via Human-Derived Stem Cell Organoids. Front Pharmacol (2016) 0.75
Modeling Cancer with Pluripotent Stem Cells. Trends Cancer (2016) 0.75
Three-dimensional pancreas organogenesis models. Diabetes Obes Metab (2016) 0.75
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing. Am J Transl Res (2016) 0.75
A process engineering approach to increase organoid yield. Development (2017) 0.75
Organoids as a Model for Colorectal Cancer. Curr Colorectal Cancer Rep (2016) 0.75
Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing. Oncogene (2016) 0.75
Gastrointestinal Organoids: Understanding the Molecular Basis of the Host-Microbe Interface. Cell Mol Gastroenterol Hepatol (2016) 0.75
Three-dimensional models for studying development and disease: moving on from organisms to organs-on-a-chip and organoids. Integr Biol (Camb) (2016) 0.75
Colorectal cancer models for novel drug discovery. Expert Opin Drug Discov (2015) 0.75
Generation of genetically modified mice using CRISPR/Cas9 and haploid embryonic stem cell systems. Dongwuxue Yanjiu (2016) 0.75
Intensive Immunofluorescence Staining Methods for Low Expression Protein: Detection of Intestinal Stem Cell Marker LGR5. Acta Histochem Cytochem (2015) 0.75
Functional exploration of colorectal cancer genomes using Drosophila. Nat Commun (2016) 0.75
Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer. Inflamm Bowel Dis (2016) 0.75
Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease. EMBO Mol Med (2017) 0.75
A protocol for the identification and validation of novel genetic causes of kidney disease. BMC Nephrol (2015) 0.75
Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation. Oncogene (2017) 0.75
Stem Cells in Repair of Gastrointestinal Epithelia. Physiology (Bethesda) (2017) 0.75
Three-Dimensional Cell Cultures in Drug Discovery and Development. SLAS Discov (2017) 0.75
CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound defects of the cell cycle. PLoS One (2017) 0.75
High-Throughput Imaging for the Discovery of Cellular Mechanisms of Disease. Trends Genet (2017) 0.75
CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery. Trends Cancer (2016) 0.75
The potential of organoids in urological cancer research. Nat Rev Urol (2017) 0.75
Multifaceted Interpretation of Colon Cancer Stem Cells. Int J Mol Sci (2017) 0.75
Genome editing: a robust technology for human stem cells. Cell Mol Life Sci (2017) 0.75
Cancer stem cells revisited. Nat Med (2017) 0.75
Beyond editing to writing large genomes. Nat Rev Genet (2017) 0.75
Synthetic lethality and cancer. Nat Rev Genet (2017) 0.75
CRISPR/Cas9: Transcending the Reality of Genome Editing. Mol Ther Nucleic Acids (2017) 0.75
Early detection: the impact of genomics. Virchows Arch (2017) 0.75
Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids. Oncotarget (2017) 0.75
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures. Oncotarget (2017) 0.75
Modeling of Autism Using Organoid Technology. Mol Neurobiol (2016) 0.75
Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol (2015) 1.05
Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer. Cancer Res (2015) 0.89
Efficient genetic engineering of human intestinal organoids using electroporation. Nat Protoc (2015) 0.87
Active and water-soluble form of lipidated Wnt protein is maintained by a serum glycoprotein afamin/α-albumin. Elife (2016) 0.80
Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites. Invest New Drugs (2016) 0.78
Has widespread use of biologic and immunosuppressant therapy for ulcerative colitis affected surgical trends? Results of a questionnaire survey of surgical institutions in Japan. Surg Today (2015) 0.78
Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: diagnosis, management, risk factors, and incidence. Dig Endosc (2016) 0.77
Successful Surveillance Colonoscopy for Patients with Ulcerative Colitis After Ileorectal Anastomosis. J Crohns Colitis (2015) 0.77
Causes of Cancer Death Among First-Degree Relatives in Japanese Families with Lynch Syndrome. Anticancer Res (2016) 0.76
Visualization and targeting of LGR5(+) human colon cancer stem cells. Nature (2017) 0.75
Analysis of anastomotic leakage after rectal surgery: A case-control study. Ann Med Surg (Lond) (2015) 0.75
Advancing Intestinal Organoid Technology Toward Regenerative Medicine. Cell Mol Gastroenterol Hepatol (2017) 0.75
Microsatellite Status of Primary Colorectal Cancer Predicts the Incidence of Postoperative Colorectal Neoplasms. Anticancer Res (2017) 0.75
Optimal Interval for 18F-FDG-PET After Chemoradiotherapy for Rectal Cancer. Clin Colorectal Cancer (2017) 0.75
Robotic surgery for rectal cancer. Asian J Endosc Surg (2017) 0.75
Outcome of salvage surgery for colorectal cancer initially treated by upfront endoscopic therapy. Surgery (2015) 0.75
Multicenter analysis of impact of anastomotic leakage on long-term oncologic outcomes after curative resection of colon cancer. Surgery (2017) 0.75